d-alpha tocopherol has been researched along with Disease Exacerbation in 224 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 35 (15.63) | 18.2507 |
| 2000's | 106 (47.32) | 29.6817 |
| 2010's | 76 (33.93) | 24.3611 |
| 2020's | 7 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Douros, K; Loukou, I; Moustaki, M; Plyta, M; Sardeli, O | 1 |
| Farina, N; Isaac, MGEKN; Llewellyn, D; Tabet, N | 1 |
| Guidi, G; Intorre, L; Lippi, I; Mannarini, C; Meucci, V; Perondi, F | 1 |
| Bak, MJ; Cai, L; Das Gupta, S; Lee, MJ; Lin, Y; Patel, M; Shih, WJ; Suh, N; Wahler, J; Wall, B; Yang, CS | 1 |
| Hyun, DH | 1 |
| Chen, CS; Ho, CT; Ho, YS; Huang, CS; Lee, CH; Lee, WJ; Tam, KW; Tu, SH; Wu, CH | 1 |
| Auinger, P; Cain, KC; Cholerton, B; Ginghina, C; Liu, C; Shi, M; Stewart, T; Zhang, J | 1 |
| Arets, HG; Broos, N; Houwen, RH; Stellato, RK; van der Ent, CK; Woestenenk, JW | 1 |
| Bechtel, C; Larsen, D; Morrell, C; Page, R; Remington, R; Samar, A; Shea, TB | 1 |
| Aubourg, P; Debbabi, M; Lizard, G; Nury, T; Ragot, K; Riedinger, JM; Vejux, A; Zarrouk, A | 1 |
| Farina, N; Isaac, MG; Llewellyn, D; Tabet, N | 1 |
| Cecchini, MG; Klima, I; Peternac, D; Schwaninger, R; Studer, UE; Thalmann, GN | 1 |
| Azzi, A; Libinaki, R; Meydani, M; Negis, Y; Zingg, JM | 1 |
| Frei, B; Traber, MG | 1 |
| Babany, G; Bonny, C; Chevallier, M; Cheveau, A; Desmorat, H; Melin, P; Pinta, A; Raabe, JJ; Rouanet, S; Sogni, P; Sturm, N; Zarski, JP | 1 |
| Iwasaki, M; Manz, MC; Miyazaki, H; Taylor, GW; Yoshihara, A | 1 |
| Balcells, M; Bobryshev, YV; Edelman, ER; Kirichenko, TV; Korneev, NV; Melnichenko, AA; Myasoedova, VA; Orekhov, AN; Sobenin, IA | 1 |
| Azen, SP; Hodis, HN; Hwang, J; LaBree, L; Liu, CH; Liu, CR; Mack, WJ; Mahrer, PR; Selzer, RH; Sevanian, A | 1 |
| Babenko, IM; den Hollander, PL; El-Naggar, AK; Hittelman, WN; Hong, WK; Izzo, JG; Keck, J; Lee, JJ; Liu, DD; Papadimitrakopoulou, VA; Shin, DM | 1 |
| Itoshima, T; Kawaguchi, M; Okita, M; Osawa, T; Ota, Y; Sakai, N; Sasagawa, T; Tomioka, K | 1 |
| Kaye, JA; Montine, KS; Montine, TJ; Moore, M; Morrow, JD; Quinn, JF | 1 |
| Lykkesfeldt, J; Poulsen, HE; Viscovich, M | 1 |
| Hayton, SM; Kriss, T; Muller, DP; Wade, A | 1 |
| Choi, JS; Choi, MK; Kim, KH; Ku, JL; Lee, E; Lee, YJ; Lim, SJ | 1 |
| Baniel, J; Gur, U; Lichtenberg, D; Neumann, A; Pinchuk, I; Yossepowitch, O | 1 |
| Campolo, J; Caruso, R; Cighetti, G; De Maria, R; Frigerio, M; Oliva, F; Parodi, O; Parolini, M; Roubina, E; Vitali, E | 1 |
| Abuja, PM | 1 |
| Azzi, A; Ricciarelli, R; Zingg, JM | 1 |
| Abdelaziz, AE; Abdelkawy, KS; Ali, AA; Elbarbry, F; Fouda, A; Hussien, M | 1 |
| Akış, M; Durmaz Engin, C; Engin, KN; Güner Akdoğan, G; Harmancı Karagülle, D; İşlekel, H; Kant, M; Özel Yıldız, S; Söylev Bajin, M; Yaman, A | 1 |
| Browne, D; McGuinness, B; McKay, GJ; Woodside, JV | 1 |
| Atkin, SL; De Vincentis, A; Jamialahmadi, T; Mahjoubin-Tehran, M; Mantzoros, CS; Mikhailidis, DP; Sahebkar, A | 1 |
| Abd El-Fattah, AI; Abu-Elfotuh, K; Ali, AA; Elariny, HA | 1 |
| Banini, BA; Sanyal, AJ | 1 |
| Alisi, A; Crudele, A; Della Corte, C; Fauler, G; Jahnel, J; Mosca, A; Nobili, V; Zöhrer, E | 1 |
| Evans, JR; Lawrenson, JG | 1 |
| Armengol, L; Arola, L; Caimari, A; Maria Del Bas, J; Mariné, S; Moriña, D; Puiggròs, F; Rodríguez, B; Rodríguez, MA | 1 |
| Bergman, H; Maayan, N; Soares-Weiser, K | 1 |
| Aibana, O; Becerra, MC; Calderon, R; Contreras, C; Franke, MF; Galea, JT; Huang, CC; Lecca, L; Murray, MB; Smith, ER; Yataco, R; Zhang, Z | 1 |
| McEvoy, CT; McGrattan, AM; McGuinness, B; McKinley, MC; Woodside, JV | 1 |
| Honda, Y; Imajo, K; Kessoku, T; Kobayashi, T; Nakajima, A; Ogawa, Y; Saito, S; Yoneda, M | 1 |
| Agodi, A; Barchitta, M; Bauerova, H; Hruskova, J; Jakubik, J; Kunzova, S; Maugeri, A; Medina-Inojosa, JR; Sochor, O; Vinciguerra, M | 1 |
| Cheung, A; Figueredo, C; Rinella, ME | 1 |
| Li, J; Wang, W; Wang, X; Zhang, H; Zhang, X | 1 |
| Atkison, P; Avitzur, Y; Filler, G; Noone, D; Prasad, C; Riedl, M; Sharma, AP; Siriwardena, K | 1 |
| Arosio, B; Bastiani, P; Bertagnoli, L; Boccardi, V; Casati, M; Ciccone, S; Ferri, E; Mansi, M; Mecocci, P; Rossi, PD; Scamosci, M | 1 |
| Awh, CC; Hawken, S; Kim, IK; Lane, AM; Zanke, B | 1 |
| Cecchetti, R; Fratiglioni, L; Hooshmand, B; Kåreholt, I; Kivipelto, M; Laatikainen, T; Mangialasche, F; Mecocci, P; Soininen, H; Solomon, A | 1 |
| Arroyo, LM; Asthana, S; Bakshi, RS; Chen, P; Chopra, MP; Craft, S; Cruz, AR; Dysken, MW; Gordon, K; Guarino, PD; Heidebrink, JL; Kowall, NW; Llorente, M; Loreck, DJ; Love, S; Malphurs, J; McCarten, JR; Mintzer, JE; Monnell, KA; Pallaki, M; Peduzzi, PN; Prieto, S; Sano, M; Schellenberg, GD; Segal, Y; Thielke, S; Tomaska, J; Trapp, G; Turvey, CL; Vertrees, JE; Vidal-Cardona, A; Woodman, C; Zachariah, S | 1 |
| Green, G; Le Prell, C; Miller, J; Thatcher, A | 1 |
| Bergo, MO; Ibrahim, MX; Larsson, E; Lindahl, P; Nilsson, JA; Sayin, VI | 1 |
| Chang, Q; Chen, H; Kwan, JK; Li, J; Li, L; Li, R; Liu, X; Lu, Z; Wei, C; Wu, Y; Xi, Z; Yang, X; Yeung, KL | 1 |
| Hermann, DM | 1 |
| Ahmed, S; Cardenas, W; Endy, TP; Finkelstein, JL; Kenneth, J; Mehta, S; Polhemus, ME; Stewart, AM | 1 |
| Aisen, PS; Donohue, MC; Edland, SD; Galasko, D; Moghadam, SH; Petersen, RC; Rissman, RA; Roe, AD; Sano, M; Sun, CK; Thomas, RG | 1 |
| Baglioni, M; Brancorsini, S; Cecchetti, R; Kivipelto, M; Kussmaul, L; Mangialasche, F; Mecocci, P; Monastero, R; Piobbico, D; Ruggiero, C | 1 |
| Beaumont, PE; Weaver, TR | 1 |
| Garhöfer, G; Schmetterer, L; Schmidl, D | 1 |
| Asleh, R; Berk, TA; Doros, G; Goldfarb, LJ; Gorbatov, R; Haas, T; Kam, A; Kaplan, M; Levy, AP; Levy, NS; Miller-Lotan, R; Sabo, E; Shalom, H; Suss-Toby, E; Tamir, R; Vardi, M; Veiner, HL; Ziskind, A; Zohar, Y | 1 |
| Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Munda, P; Rechling, C; Trauner, M; Traussnigg, S | 1 |
| Levy, Y | 1 |
| Bomfati, F; Karimian, G; Kirschbaum, M; Lisman, T; Porte, RJ; Veldhuis, ZJ | 1 |
| Shinohara, M; Yamada, M | 1 |
| Blankenberg, S; Chapman, MJ; Landmesser, U | 1 |
| Dufour, JF; Perazzo, H | 1 |
| Hosseini, B; Saedisomeolia, A; Skilton, MR | 1 |
| Oseini, AM; Sanyal, AJ | 1 |
| Isaac, MG; Quinn, R; Tabet, N | 1 |
| Buring, JE; Conen, D; Glynn, RJ; Ridker, PM; Zee, RY | 1 |
| Chan, AW; Chung, SK; Chung, SS; Ho, YS | 1 |
| Barkhof, F; DeCarli, C; Harvey, D; Jack, CR; Petersen, RC; Scheltens, P; Thal, LJ; van Straaten, EC | 1 |
| Aisen, PS; Ascherio, A; Becerra, LM; Irizarry, MC; Peterson, RC; Raman, R; Schwarzschild, MA; Thomas, RG | 1 |
| Ciabattoni, G; Cuccurullo, C; Davì, G; Ferroni, P; Guagnano, MT; Manigrasso, MR; Paoletti, V; Pescara, L; Santilli, F | 1 |
| Jung, KJ; Kim, J; Park, KM; Seok, YM | 1 |
| Prasad, K | 2 |
| Kagota, S; Kunitomo, M; Nakamura, K; Shinozuka, K; Yamaguchi, Y; Yoshikawa, N | 1 |
| Imada, T; Kuroiwa, Y; Rino, Y; Suzuki, Y; Takahashi, T; Takanashi, Y; Ueda, N | 1 |
| Aisen, PS; Apostolova, LG; Cummings, JL; Decarli, CS; Green, AE; Harvey, DJ; Hwang, KS; Jack, CR; Petersen, RC; Thal, LJ; Thompson, PM; Toga, AW; Zoumalan, C | 1 |
| Falcone, EL; Jones, CY; Mangili, A; Polak, JF; Tang, AM; Wanke, CA; Woods, MN | 1 |
| Hauser, RA | 1 |
| Cervi, D; Fleshner, NE; Klotz, LH; Nam, RK; Pak, B; Sugar, LM; Venier, NA; Venkateswaran, V | 1 |
| Babaev, VR; Fazio, S; Li, L; Linton, MF; May, JM; Shah, S | 1 |
| Aker, S; Brodde, OE; Canton, M; Di Lisa, F; Heusch, G; Heusch, P; Konietzka, I; Menazza, S; Rassaf, T; Schulz, R; van de Sand, A | 1 |
| Aisen, PS; Emond, J; Fleisher, AS; Petersen, RC; Raman, R; Sherzai, A; Whitehair, DC | 1 |
| Aisen, PS; Andrieu, S; Bednar, MM; Carrillo, M; Donohue, M; Doody, RS; Dubois, B; Feldman, HH; Grundman, M; Hendrix, SB; Khachaturian, ZS; Petersen, RC; Potter, WZ; Salmon, D; Salmon, E; Sampaio, C; Schindler, RJ; Schneider, LS; Siemers, E; Thomas, RG; Touchon, J; Vellas, B | 1 |
| Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J | 1 |
| Chin, J; Donnelly, B; Farley, A; Fleshner, NE; Gleave, M; Hersey, K; Jansz, K; Kapusta, L; Lacombe, L; Parulekar, WR; Siemens, DR; Tanguay, S; Trpkov, K; Tu, D | 1 |
| Ho, JN; Jeon, H; Jun, W; Kang, ER; Lee, J; Watson, RR; Yoon, HG | 1 |
| Sawyer, DB | 1 |
| Desai, AS; Fang, JC; Givertz, MM; Mudge, GH; Ujeyl, A | 1 |
| Chiocca, EA; Elkhammas, EA; Firstenberg, MS; Ganesh, K; Gnyawali, U; Gordillo, GM; Khanna, S; Kirkpatrick, R; Klatte, E; Miller, M; More, JL; Nesaretnam, K; Patel, V; Phillips, G; Rink, C; Roy, S; Sarkar, A; Sen, CK; Shneker, B | 1 |
| Aisen, PS; Cummings, J; Schneider, LS | 1 |
| Heim, L; Jaceldo-Siegl, K; Perez, L; Sherzai, A | 1 |
| Iwasaki, M; Manz, MC; Miyazaki, H; Moynihan, P; Muramatsu, K; Taylor, GW; Watanabe, R; Yoshihara, A | 1 |
| Davis, RM; Ervin, AM; Mathew, MC; Tao, J | 1 |
| Bose, KS; Singh, M; Vyas, P | 1 |
| Carothers, S; Chang, Y; Glenn Lin, CL; Kong, Q | 1 |
| Barrett-O'Keefe, Z; Fjeldstad, AS; Ives, SJ; McDaniel, J; Nativi, JN; Richardson, RS; Stehlik, J; Witman, MA; Wray, DW; Zhao, J | 1 |
| Aboud, S; Fawzi, WW; Guerino, C; Hawkins, C; Isanaka, S; Mugusi, F; Okuma, J; Spiegelman, D | 1 |
| Clark, AR; Farina, N; Isaac, MG; Rusted, J; Tabet, N | 1 |
| Alvaro, R; Brancato, T; D'Ascenzo, R; De Giorgio, G; Nupieri, P; Orsolini, G; Paulis, G | 1 |
| Abdul Manaf, Z; Abdul Manap, R; Cheraghi, M; Najafiyan, M; Pirabbasi, E; Rajab, N; Shahar, S | 1 |
| Centeno, BA; Chen, DT; Fulp, WJ; Hingorani, SR; Husain, K; Luetteke, N; Malafa, MP; Perez, M; Sebti, SM; Zhang Lee, G | 1 |
| Baglioni, M; Cecchetti, R; Floridi, P; Gobbi, G; Kivipelto, M; Kłoszewska, I; Lovestone, S; Mangialasche, F; Mecocci, P; Muehlboeck, JS; Simmons, A; Soininen, H; Spenger, C; Tarducci, R; Tsolaki, M; Vellas, B; Wahlund, LO; Westman, E | 1 |
| Cadet, C; Coste, P; Dougados, M; Grouin, JM; Halhol, H; Kerloch, I; Lequesne, M; Maheu, E; Marty, M; Mazières, B; Moyse, D; Spector, TD | 1 |
| Delaney, P; Grundman, M | 1 |
| Asensio Sánchez, VM | 1 |
| Loffredo, L; Maranghi, M; Violi, F | 1 |
| de Lorgeril, M; Salen, P | 1 |
| Pasantes-Morales, H; Quesada, O; Quiroz, H | 1 |
| Miller, SM | 1 |
| Cyrus, T; Praticò, D; Rokach, J; Tang, LX; Yao, Y | 1 |
| Brenner, SR | 1 |
| Kaikkonen, J; Lakka, HM; Nyyssönen, K; Porkkala-Sarataho, E; Poulsen, HE; Rissanen, TH; Ristonmaa, U; Salonen, JT; Salonen, RM; Tuomainen, TP; Valkonen, VP; Vanharanta, M; Voutilainen, S | 1 |
| Salonen, JT | 1 |
| Arockia Rani P, J; Fukatsu, A; Hayashi, T; Iguchi, A; Kano, H; Matsui-Hirai, H; Sumi, D; Tsunekawa, T | 1 |
| Horstink, MW; van Engelen, BG | 1 |
| Dekrét, J; Hájovská, A; Hirnerová, E; Krahulec, B; Stecová, A; Strbová, L | 1 |
| Birch, DG; Hoffman, DR; Locke, KG; Watkins, RB; Wheaton, DH | 1 |
| Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakuk, P; Tipprukmas, N; Tohsukhowong, P | 1 |
| Bressler, NM; Bressler, SB; Congdon, NG; Ferris, FL; Friedman, DS; Klein, R; Lindblad, AS; Milton, RC; Seddon, JM | 1 |
| Jampol, LM | 2 |
| Hatakeyama, Y; Nakano, N; Yoshida, T | 1 |
| Lee, VM; Praticò, D; Sung, S; Trojanowski, JQ; Uryu, K; Yang, H; Yao, Y | 1 |
| McCarty, CA; McNeil, JJ; Robman, L; Sinclair, MI; Taylor, HR; Tikellis, G | 1 |
| Bittner, V; Cobb, FR; Friedenberg, P; Higginson, L; Howard, BV; Levy, AP; Lotan, R; Ouyang, P; Tardif, JC; Tripputi, M | 1 |
| Aljama, P; Bárány, P; Cameron, S; Canaud, B; Carrera, F; Eckardt, KU; Hörl, WH; Locatelli, F; Macdougal, IC; Macleod, A; Wiecek, A | 1 |
| Alderson, NL; Baynes, JW; Canning, P; Chachich, ME; Frizzell, N; Januszewski, AS; Metz, TO; Stitt, AW; Thorpe, SR; Youssef, NN | 1 |
| Giuliani, A; Sánchez, GM; Trueba, GP | 1 |
| Belhabib, D; Ghawar, C; Maalej, M; Trabelsi Alouane, L; Tritar Cherif, F | 1 |
| Raskatovas, D | 1 |
| Gajdosik, A; Gajdosikova, A; Karasu, C; Kyselova, Z; Mihalova, D; Stefek, M; Ulicna, O | 1 |
| Hikiami, H; Kainuma, M; Kouta, K; Nakagawa, T; Sekiya, N; Shibahara, N; Shimada, Y; Terasawa, K | 1 |
| Bennett, D; Doody, R; Ferris, S; Galasko, D; Grundman, M; Jin, S; Kaye, J; Levey, A; Petersen, RC; Pfeiffer, E; Sano, M; Thal, LJ; Thomas, RG; van Dyck, CH | 1 |
| Blacker, D | 1 |
| Csiba, L | 1 |
| Barnes, DE; Yaffe, K | 1 |
| Cockburn, DM | 1 |
| Al-Osaimi, AM; Argo, CK; Caldwell, SH; Chang, CY | 1 |
| Behrendt, D; Beltrame, J; Fang, JC; Ganz, P; Hikiti, H; Kinlay, S; Selwyn, AP; Wainstein, M | 1 |
| Imai, Y; Inui, K; Kobayashi, T; Nakazawa, S; Ohta, Y; Yoshino, J | 1 |
| Chan, JC; Trachtman, H | 1 |
| Castellani, RJ; Moreira, PI; Nunomura, A; Perry, G; Smith, MA; Zhu, X | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Hu, Y; Jin, ML; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Xu, GW; You, WC; Zhang, L | 1 |
| Branley, P; Demos, L; Kotsopoulos, D; Magliano, D; McGrath, B; McNeil, J; Shiel, L; Wolfe, R | 1 |
| Appel, LJ; Bleys, J; Guallar, E; Miller, ER; Pastor-Barriuso, R | 1 |
| Mchedlidze M G, MG; Shioshvili, TI | 1 |
| Baylis, C; Dikalova, A; Freshour, G; Griendling, K; Tain, YL | 1 |
| Clark, CM; DeCarli, C; Frisoni, GB; Grundman, M; Harvey, D; Jack, CR; Jin, S; Petersen, RC; Scheltens, P; Thal, LJ | 1 |
| Aebischer, C; Andrade, O; Bravo, JC; Buiatti, E; Cano, E; Carillo, E; Castro, D; Franceschi, S; Garcia, R; Lopez, G; Muñoz, N; Oliver, W; Peraza, S; Plummer, M; Sánchez, V; Vivas, J | 1 |
| Fleisher, AS; Gamst, AC; Petersen, RC; Sowell, BB; Taylor, C; Thal, LJ | 1 |
| Gagnon, E; Robinson, B; Small, BJ | 1 |
| Capasso, R; D'Auria, MV; de Sio, I; Del Vecchio Blanco, C; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C | 1 |
| Chan, JC; Chiu, MC; Hisano, S | 1 |
| Corrado Balacco, G; Fehér, J; Kovács, B; Kovács, I; Schvöller, M | 1 |
| Coppo, R | 1 |
| Bavaresco, CS; Chiarani, F; de Souza Wyse, AT; Kolling, J; Netto, CA | 1 |
| Moats, C; Rimm, EB | 1 |
| Evans, J | 1 |
| Ayub, K; Blount, PL; Dong, LM; Kristal, AR; Odze, RD; Peters, U; Rabinovitch, PS; Reid, BJ; Sanchez, CA; Schenk, JM; Vaughan, TL | 1 |
| Cecchetti, R; Forti, P; Lucicesare, A; Mangialasche, F; Mecocci, P; Patterson, C; Pisacane, N; Ravaglia, G; Rietti, E | 1 |
| Fujishima, M; Nanishi, F; Okuda, S; Onoyama, K; Washio, M | 1 |
| Astore, D; Bellomo, G; Castellano, R; Chiesa, R; Finardi, G; Grossi, A; Maggi, E; Melissano, G | 1 |
| Aliabadi, P; Felson, DT; Hannan, MT; Jacques, P; Levy, D; McAlindon, TE; Rush, D; Weissman, B; Zhang, Y | 1 |
| Andrade, O; Axon, AT; Benz, M; Cano, E; Castro, D; de Sanjosé, S; Muñoz, N; Oliver, W; Peraza, S; Sanchez, V; Schorah, CJ; Sobala, G; Tompkins, D; Vivas, J | 1 |
| Astre, C; Gerber, M; Pujol, H; Saintot, M | 1 |
| Bruschke, AV; De Rijke, YB; Princen, HM; Van Berkel, TJ; Van Der Laarse, A; Van Der Velde, EA; Verwey, HF; Vogelezang, CJ | 1 |
| Rouhiainen, H; Rouhiainen, P; Salonen, JT | 1 |
| Brinton, LA; Potischman, N | 1 |
| Bodlaj, R; Finckh, B; Freudenberg, K; Hübner, C; Kohlschütter, A; Kontush, A; Lehr, HA; Marklund, SL; Oexle, K; Speer, A; Terwolbeck, K; Voit, T | 1 |
| Doris, CI; Dzavik, V; Hutchison, K; Lonn, EM; Pogue, J; Riley, WA; Sabine, MJ; Taylor, W; Tucker, J; Yusuf, S | 1 |
| Azen, SP; Hodis, HN; Liu, CH; Liu, CR; Mack, WJ; Qian, D; Selzer, RH; Sevanian, A | 1 |
| Andrus, PK; Cutting, FB; Doble, A; Gurney, ME; Hall, ED; Taylor, CP; Zhai, P | 1 |
| Cotman, CW; Ernesto, C; Growdon, J; Grundman, M; Klauber, MR; Pfeiffer, E; Sano, M; Schafer, K; Schneider, LS; Thal, LJ; Thomas, RG; Woodbury, P | 1 |
| Chamuleau, RA; Groenink, M; Hoek, FJ; Reitsma, PH; van Deventer, SJ; Wu, CG | 1 |
| Adelman, A | 1 |
| Arencibia, R; Broche, F; Castellano, O; Céspedes, EM; García, JC; Gómez, AA; González-Fraguela, ME | 1 |
| Andrus, PK; Fleck, TJ; Gurney, ME; Hall, ED; Oostveen, JA | 1 |
| de Jong, JM; Guchelaar, HJ; Haasdijk, E; Holstege, JC; Jaarsma, D | 1 |
| Shoulson, I | 1 |
| Sloane, PD | 1 |
| Nicholson, CR | 1 |
| Brumfield, SK; Moyad, MA; Pienta, KJ | 1 |
| Post, SG | 1 |
| Ishiguro, I; Majima, Y; Niwa, T; Ohta, Y; Yamasaki, T | 1 |
| Ciomârtan, T; Gafencu, O; Nascutzy, C | 1 |
| Eriksson, LC; Olsson, JM; Stål, P; Wang, GS | 2 |
| Garrett, SK; Harper, CA; McCarty, CA; McNeil, JJ; Robman, LD; Taylor, HR; Tikellis, G | 1 |
| Kumagai, S; Shibata, H; Suzuki, T; Watanabe, S | 1 |
| Albanes, D; Aro, A; Haukka, JK; Huttunen, JK; Törnwall, ME; Virtamo, J | 1 |
| Joffe, BI; Kotze, MJ; Pilcher, GJ; Raal, FJ; Veller, MG | 1 |
| Abdalla, DS; Miranda, AF; Moriel, P; Oliveira, OV; Silveira, MV; Spada, C; Treitinger, A; Verdi, JC | 1 |
| Maruyama, K; Usuki, F | 1 |
| Majima, Y; Niwa, T; Ohta, Y; Yamasaki, T | 1 |
| Applegate, WB; Chesney, CM; Davis, KB; Elam, MB; Garg, R; Herd, JA; Hunninghake, D; Kennedy, JW | 1 |
| Biesalski, HK; Braun, N; Frank, J; Risler, T | 1 |
| Bregnocchi, M; Cecchetti, R; Cherubini, A; di Iorio, A; Ingegni, T; Mecocci, P; Pezzuto, S; Polidori, MC; Senin, U | 1 |
| Kaikkonen, J; Lakka, HM; Lakka, TA; Leskinen, L; Nyyssönen, K; Porkkala-Sarataho, E; Poulsen, HE; Rissanen, T; Ristonmaa, U; Salonen, JT; Salonen, R; Tuomainen, TP; Valkonen, VP; Voutilainen, S | 1 |
| Reichman, WE | 1 |
| Bosch, J; Doris, C; Dzavik, V; Lonn, E; Moore-Cox, A; Riley, W; Smith, S; Teo, K; Yi, Q; Yusuf, S | 1 |
| Chan, JC; Chan, W; Krieg, RJ; Lin, KC; Santos, F; Ward, K | 1 |
| Kontush, A; Neuzil, J; Weber, C | 1 |
| Ciecierski, M; Gackowski, D; Jawien, A; Kruszewski, M; Olinski, R | 1 |
| Cyrus, T; FitzGerald, GA; Praticò, D; Rokach, J; Tang, LX | 1 |
| Casanada, F; Condorelli, M; D'Armiento, FP; de Nigris, F; Napoli, C; Palinski, W; Silvestre, M; Witztum, JL | 1 |
| Harrison, DG; Landmesser, U | 1 |
| Moyad, MA | 1 |
| Iuliano, L; Micheletta, F; Spagnoli, LG; Violi, F | 1 |
| Bron, A; Brown, NP; Chylack, LT; Hurst, M; Köpcke, W; Schalch, W; Thien, U | 1 |
| Behrendt, D; Beltrame, J; Fang, JC; Frei, B; Ganz, P; Hikiti, H; Kinlay, S; Mudge, GH; Selwyn, AP; Suh, J; Wainstein, M | 1 |
| Cherubini, A; Mecocci, P; Polidori, MC; Senin, U; Sies, H; Stahl, W | 1 |
| McCarty, CA; McNeil, JJ; Robman, LD; Taylor, HR; Tikellis, G | 1 |
54 review(s) available for d-alpha tocopherol and Disease Exacerbation
| Article | Year |
|---|---|
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: Activities of Daily Living; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognition; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2017 |
Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases.
Topics: Aging; alpha-Tocopherol; Animals; Caloric Restriction; Cell Membrane; Cell Survival; Disease Progression; Down-Regulation; Free Radicals; Humans; Mitochondria; Models, Animal; NADH, NADPH Oxidoreductases; Neurodegenerative Diseases; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Phytochemicals; Up-Regulation | 2019 |
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2017 |
Vitamin E 80th anniversary: a double life, not only fighting radicals.
Topics: alpha-Tocopherol; Animals; Arteriosclerosis; Disease Progression; Free Radical Scavengers; Free Radicals; Gene Expression Regulation; Humans; Nervous System Diseases; Transcription, Genetic; Vitamin E; Vitamin E Deficiency | 2001 |
Vitamin E and Alzheimer's disease: what do we know so far?
Topics: Alzheimer Disease; Cholesterol; Diet; Dietary Supplements; Disease Progression; Humans; Male; Nutritional Status; Treatment Outcome; Vitamin E | 2019 |
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis.
Topics: Biopsy; Disease Progression; Humans; Liver; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Aged; Antioxidants; Dietary Supplements; Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Minerals; Quality of Life; Randomized Controlled Trials as Topic; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2017 |
Vitamin E for antipsychotic-induced tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Disease Progression; Dyskinesia, Drug-Induced; Humans; Patient Acceptance of Health Care; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E; Vitamins | 2018 |
Effect of dietary interventions in mild cognitive impairment: a systematic review.
Topics: Alzheimer Disease; Attention; Biomarkers; Cognition; Cognitive Dysfunction; Dementia; Diet; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Folic Acid; Ginkgo biloba; Humans; Language; Neuropsychological Tests; Phospholipids; Randomized Controlled Trials as Topic; Vitamin E | 2018 |
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults.
Topics: Adult; Diet; Disease Progression; Drug Development; Humans; Life Style; Non-alcoholic Fatty Liver Disease; Pioglitazone; Vitamin E | 2019 |
Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients.
Topics: Biomarkers; Biopsy; Diagnostic Imaging; Diet; Disease Progression; Humans; Hypoglycemic Agents; Life Style; Liver Transplantation; Non-alcoholic Fatty Liver Disease; Pioglitazone; Vitamin E | 2019 |
Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis.
Topics: Alzheimer Disease; Dietary Supplements; Disease Progression; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E | 2021 |
Micronutrients and dengue.
Topics: Chromium; Dengue; Dengue Virus; Dietary Supplements; Disease Progression; Humans; Iron, Dietary; Micronutrients; Observational Studies as Topic; Randomized Controlled Trials as Topic; Vitamin A; Vitamin D; Vitamin E; Zinc | 2014 |
Nutritional supplements in age-related macular degeneration.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; beta Carotene; Copper; Dietary Supplements; Disease Progression; Drug Combinations; Humans; Lutein; Macular Degeneration; Vision Disorders; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2015 |
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Topics: Anticholesteremic Agents; Antioxidants; Bariatric Surgery; Carcinoma, Hepatocellular; Disease Progression; Genetic Variation; Humans; Hypoglycemic Agents; Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Membrane Proteins; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Prognosis; Receptors, Cytoplasmic and Nuclear; Vitamin E | 2015 |
[Vitamin E and Alzheimer's Disease].
Topics: Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Oxidative Stress; Vitamin E | 2015 |
The year in cardiology 2015: prevention.
Topics: Adrenocorticotropic Hormone; Antibodies, Monoclonal; Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Diabetic Angiopathies; Disease Progression; Dyslipidemias; Global Health; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoprotein(a); PCSK9 Inhibitors; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Risk Assessment; Therapies, Investigational; Vitamin E | 2016 |
The therapeutic landscape of non-alcoholic steatohepatitis.
Topics: Antioxidants; Chalcones; Chenodeoxycholic Acid; Disease Progression; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Pioglitazone; Propionates; Randomized Controlled Trials as Topic; Thiazolidinediones; Vitamin E; Weight Loss | 2017 |
Association between Micronutrients Intake/Status and Carotid Intima Media Thickness: A Systematic Review.
Topics: Antioxidants; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; Databases, Factual; Disease Progression; Humans; Iron; Magnesium; Micronutrients; Nutritional Status; Randomized Controlled Trials as Topic; Risk Factors; Vitamin A; Vitamin B Complex; Vitamin D; Vitamin E; Zinc | 2017 |
Therapies in non-alcoholic steatohepatitis (NASH).
Topics: Carcinoma, Hepatocellular; Diet; Disease Progression; Exercise; Fibrosis; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Non-alcoholic Fatty Liver Disease; Pioglitazone; Randomized Controlled Trials as Topic; Risk Factors; Thiazolidinediones; Vitamin E | 2017 |
Vitamin E for Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
Early pharmacologic treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Disease Progression; Dopamine Agonists; Early Diagnosis; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Ubiquinone; Vitamin E | 2010 |
Natural products in regression and slowing of progression of atherosclerosis.
Topics: Animals; Antioxidants; Atherosclerosis; Biological Products; Butylene Glycols; Disease Progression; Flax; Glucosides; Humans; Hypercholesterolemia; Lignans; Oxidative Stress; Phytotherapy; Vitamin E | 2010 |
[Fatty liver and its clinical management in obese adolescents].
Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2011 |
Oxidative stress in heart failure: what are we missing?
Topics: Animals; Antioxidants; Cell Death; Disease Progression; Heart Failure; Humans; Nitric Oxide Synthase; Oxidative Stress; Reactive Oxygen Species; Ventricular Remodeling; Vitamin E | 2011 |
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Topics: Alkaloids; Alzheimer Disease; Amino Acids; Animals; Cholinesterase Inhibitors; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Donepezil; Drug Approval; Galantamine; Ginkgo biloba; Half-Life; History, 20th Century; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Psychotropic Drugs; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Sesquiterpenes; Vitamin B Complex; Vitamin E | 2012 |
Nutrition and vascular dementia.
Topics: Animals; Antioxidants; Ascorbic Acid; Cholesterol; Cognition Disorders; Dementia, Vascular; Diet; Disease Progression; Fishes; Folic Acid; Humans; Meat; Nutritional Status; Prevalence; Risk Factors; Vitamin B 12; Vitamin E | 2012 |
Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cataract; Disease Progression; Humans; Middle Aged; Vitamin E; Vitamins | 2012 |
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2012 |
Antioxidant strategies for Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Ginkgo biloba; Humans; Oxidation-Reduction; Oxidative Stress; Vitamin E | 2002 |
Clinical trials testing cardiovascular benefits of antioxidant supplementation.
Topics: Aged; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cardiovascular System; Clinical Trials as Topic; Disease Progression; Female; Humans; Male; Middle Aged; Time Factors; Vitamin E | 2002 |
[Mild cognitive impairment].
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Disease Progression; Humans; Psychiatric Status Rating Scales; Selegiline; Severity of Illness Index; Vitamin E | 2003 |
Oxygen free radical and antioxidant defense mechanism in cancer.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Ascorbic Acid; Carotenoids; Disease Progression; DNA Damage; Free Radicals; Humans; Immunohistochemistry; Micronutrients; Models, Biological; Mutagenesis; Neoplasms; Oxidation-Reduction; Oxygen; Selenium; Vitamin A; Vitamin E | 2004 |
[Chemoprevention possibilities of lung cancer].
Topics: Antioxidants; Disease Progression; Double-Blind Method; Female; Humans; Isotretinoin; Lung Neoplasms; Male; Middle Aged; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Smoking; Smoking Cessation; Time Factors; Vitamin E | 2004 |
[Carotid intima-media thickness measured by ultrasonography: effect of different pharmacotherapies on atherosclerosis progression].
Topics: Antihypertensive Agents; Ascorbic Acid; Cardiovascular Agents; Carotid Arteries; Carotid Stenosis; Disease Progression; Estradiol; Humans; Hypolipidemic Agents; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography; Vitamin E | 2005 |
Therapy of NAFLD: antioxidants and cytoprotective agents.
Topics: Acetylcysteine; Antioxidants; Betaine; Cholagogues and Choleretics; Disease Progression; Fatty Liver; Humans; Lipid Peroxidation; S-Adenosylmethionine; Ursodeoxycholic Acid; Vitamin E | 2006 |
Modulating the progression in IgA nephropathy.
Topics: Adolescent; Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Combined Modality Therapy; Disease Progression; Fish Oils; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Tonsillectomy; Vitamin E | 2006 |
Involvement of oxidative stress in Alzheimer disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Cell Death; Disease Models, Animal; Disease Progression; Genetic Predisposition to Disease; Humans; Neurons; Neuroprotective Agents; Oxidative Stress; Plaque, Amyloid; Risk Factors; Risk Reduction Behavior; Vitamin E | 2006 |
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Antioxidants; Ascorbic Acid; Atherosclerosis; beta Carotene; Coronary Artery Disease; Dietary Supplements; Disease Progression; Female; Folic Acid; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selenium; Trace Elements; Ultrasonography, Interventional; Vitamin B 12; Vitamin B 6; Vitamin E; Vitamins | 2006 |
Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
Topics: Adult; Alzheimer Disease; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Neuropsychological Tests; Nootropic Agents; Piperidines; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Time Factors; Vitamin E | 2007 |
[Metabolic therapy for early treatment of age-related macular degeneration].
Topics: Acetylcarnitine; Adenosine Triphosphate; Antioxidants; Ascorbic Acid; beta Carotene; Coenzymes; Disease Progression; Drug Therapy, Combination; Fatty Acids, Omega-3; Humans; Hungary; Lipid Peroxidation; Macular Degeneration; Mitochondria; Photoreceptor Cells; Pigment Epithelium of Eye; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Severity of Illness Index; Treatment Outcome; Ubiquinone; Visual Acuity; Visual Fields; Vitamin E; Vitamins; Zinc Compounds | 2007 |
Pediatric IgA nephropathy: clinical and therapeutic perspectives.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Contraindications; Disease Progression; Follow-Up Studies; Glomerulonephritis, IGA; Hematuria; Humans; Proteinuria; Randomized Controlled Trials as Topic; Steroids; Tonsillectomy; Vitamin E; Vitamins | 2008 |
Vitamin intake and risk of coronary disease: observation versus intervention.
Topics: Antioxidants; Atherosclerosis; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Dietary Supplements; Disease Progression; Humans; Incidence; Micronutrients; Primary Prevention; Vitamin B Complex; Vitamin D; Vitamin E; Vitamins | 2007 |
Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Antioxidants; beta Carotene; Control Groups; Dietary Supplements; Disease Progression; Female; Humans; Macular Degeneration; Male; Randomized Controlled Trials as Topic; Vitamin E; Vitamins | 2008 |
Nutrition and cervical neoplasia.
Topics: Ascorbic Acid; Carotenoids; Developing Countries; Disease Progression; Female; Folic Acid; Humans; Nutritional Physiological Phenomena; Papillomaviridae; Papillomavirus Infections; Precancerous Conditions; Public Health; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vitamin E | 1996 |
DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.
Topics: Antioxidants; Antiparkinson Agents; Clinical Trials as Topic; Disease Progression; Humans; Neuroprotective Agents; Parkinson Disease; Selegiline; Vitamin E | 1998 |
Advances in the treatment of Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Decision Trees; Diagnosis, Differential; Disease Progression; Estrogens; Humans; Mental Disorders; Terminal Care; Vitamin E | 1998 |
Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
Topics: Dietary Fats; Disease Progression; Drug Screening Assays, Antitumor; Humans; Incidence; Male; Morbidity; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 1999 |
Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Estrogen Replacement Therapy; Ethics, Medical; Genetic Predisposition to Disease; Genetic Testing; Ginkgo biloba; Health Priorities; Humans; Phytotherapy; Plants, Medicinal; Risk Factors; Vitamin E | 1999 |
[Retinopathy of prematurity].
Topics: Antioxidants; Cryotherapy; Diagnosis, Differential; Disease Progression; Humans; Infant, Newborn; Infant, Premature; Laser Coagulation; Prognosis; Retinopathy of Prematurity; Vitamin E | 1998 |
Alzheimer's disease: clinical treatment options.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Antioxidants; Antipsychotic Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Disease Progression; Estrogens; Humans; Nootropic Agents; United States; Vitamin E | 2000 |
The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease.
Topics: Animals; Arteriosclerosis; Disease Progression; Humans; Immune System; Oxidation-Reduction; Signal Transduction; Vitamin E | 2001 |
New tools for taking control of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Humans; Practice Guidelines as Topic; Risk Factors; Vitamin E | 2001 |
Results and lessons from clinical trials using dietary supplements for cancer: direct and indirect investigations.
Topics: Acetylcysteine; Amygdalin; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tissue Extracts; Vitamin A; Vitamin E | 2001 |
57 trial(s) available for d-alpha tocopherol and Disease Exacerbation
| Article | Year |
|---|---|
Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.
Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; alpha-Tocopherol; Antiparkinson Agents; Cognition Disorders; Cohort Studies; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Selegiline | 2014 |
Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Cognition Disorders; Dietary Supplements; Disease Progression; Female; Folic Acid; Follow-Up Studies; Humans; Male; Mood Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Time Factors; Vitamin B 12 | 2016 |
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Topics: Adult; alpha-Tocopherol; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Female; France; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; RNA, Viral; Time Factors; Treatment Outcome | 2010 |
Anti-atherosclerotic therapy based on botanicals.
Topics: Adult; Aged; alpha-Tocopherol; Ascorbic Acid; beta Carotene; Biomarkers; Cardiovascular Agents; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol; Disease Progression; Double-Blind Method; Garlic; Humans; Male; Middle Aged; Phytotherapy; Plant Preparations; Plants, Medicinal; Time Factors; Treatment Outcome | 2013 |
Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Arteriosclerosis; Carotid Artery, Common; Dietary Supplements; Disease Progression; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Patient Compliance; Tunica Intima; Tunica Media; Ultrasonography | 2002 |
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Cyclin D1; Disease Progression; Gene Expression Regulation, Neoplastic; Genotype; Humans; Immunohistochemistry; Immunologic Factors; In Situ Hybridization, Fluorescence; Interferon-alpha; Isotretinoin; Laryngeal Neoplasms; Mouth Neoplasms; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prospective Studies; Treatment Outcome | 2003 |
Vitamin C pharmacokinetics of plain and slow release formulations in smokers.
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Area Under Curve; Arteriosclerosis; Ascorbic Acid; Delayed-Action Preparations; Disease Progression; Humans; Intestinal Absorption; Male; Middle Aged; Single-Blind Method; Smoking | 2004 |
A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
Topics: Adult; Antioxidants; Cholagogues and Choleretics; Disease Progression; Egypt; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Single-Blind Method; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
Topics: Adolescent; Biomarkers; Biopsy; Child; Child Nutritional Physiological Phenomena; Choline; Combined Modality Therapy; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Exercise; Female; Follow-Up Studies; Healthy Lifestyle; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Severity of Illness Index; Vitamin E | 2017 |
CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
Topics: Aged; Alleles; Antioxidants; Ascorbic Acid; beta Carotene; Complement Factor H; Dietary Supplements; Disease Progression; Female; Humans; Macular Degeneration; Male; Pharmacogenetics; Polymorphism, Single Nucleotide; Prospective Studies; Proteins; Risk Factors; Vitamin E; Vitamins; Zinc Compounds | 2013 |
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Caregivers; Cholinesterase Inhibitors; Disease Progression; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Middle Aged; Severity of Illness Index; Treatment Outcome; Vitamin E | 2014 |
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Blood Chemical Analysis; Cognitive Dysfunction; Disease Progression; Donepezil; Female; Heterozygote; Humans; Indans; Longitudinal Studies; Male; Nootropic Agents; Peptide Fragments; Piperidines; Severity of Illness Index; Simvastatin; Vitamin E | 2015 |
The effect of intensive education on concordance with the Age-Related Eye Disease Study (AREDS) recommendations in a tertiary referral practice.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Female; Guidelines as Topic; Humans; Macular Degeneration; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Prospective Studies; Surveys and Questionnaires; Tertiary Care Centers; Vitamin E; Vitamins; Zinc | 2015 |
Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.
Topics: Angiotensinogen; Antioxidants; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Disease Progression; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Hypertension, Renal; Incidence; Middle Aged; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Vitamin E | 2008 |
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Atrophy; Brain; Cerebral Ventricles; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Disease Progression; Donepezil; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Piperidines; Prospective Studies; Temporal Lobe; Time Factors; Treatment Outcome; Vitamin E | 2008 |
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
Topics: Aged; Alzheimer Disease; Atrophy; Cognition Disorders; Disease Progression; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nootropic Agents; Severity of Illness Index; Vitamin E | 2010 |
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Topics: Disease Progression; Disease-Free Survival; Double-Blind Method; Humans; Male; Middle Aged; Patient Compliance; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Soybean Proteins; Testosterone; Vitamin E | 2011 |
Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study.
Topics: Angioplasty, Balloon, Coronary; Ascorbic Acid; Coronary Artery Disease; Disease Progression; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Tunica Intima; Vascular Diseases; Vitamin E | 2011 |
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients.
Topics: Adult; Biological Transport, Active; Dietary Supplements; Disease Progression; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Prospective Studies; Tissue Distribution; Tocopherols; Tocotrienols; Vitamin E | 2012 |
Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.
Topics: Adult; Antiretroviral Therapy, Highly Active; Ascorbic Acid; Body Mass Index; CD4 Lymphocyte Count; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; Humans; Male; Nutritional Status; Survival Analysis; Treatment Outcome; Viral Load; Vitamin B Complex; Vitamin E; Vitamins | 2012 |
Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blueberry Plants; Calcium Channel Blockers; Diclofenac; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Fruit; Humans; Injections, Intralesional; Iontophoresis; Male; Middle Aged; Penile Induration; Propolis; Rome; Severity of Illness Index; Time Factors; Treatment Outcome; Verapamil; Vitamin E; Vitamins | 2013 |
Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Pain Measurement; Phytosterols; Phytotherapy; Plant Extracts; Prospective Studies; Radiography; Severity of Illness Index; Treatment Outcome; Vitamin E | 2014 |
[AREDS and age-related macular degeneration].
Topics: Age of Onset; Aged; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Disease Progression; Humans; Macular Degeneration; Middle Aged; National Institutes of Health (U.S.); Orthomolecular Therapy; United States; Vitamin E; Zinc | 2002 |
Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Topics: Adolescent; Adult; Angiography; Antioxidants; Calcium Channel Blockers; Child; Diltiazem; Disease Progression; Double-Blind Method; Electroretinography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Photoreceptor Cells, Vertebrate; Retinitis Pigmentosa; Taurine; Visual Acuity; Visual Fields; Vitamin E | 2002 |
Vitamin E may worsen acute respiratory tract infections in the elderly.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Confidence Intervals; Dietary Supplements; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Probability; Reference Values; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome; Vitamin E | 2002 |
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study.
Topics: Aged; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, HDL; Delayed-Action Preparations; Dietary Supplements; Disease Progression; Drug Therapy, Combination; F2-Isoprostanes; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Patient Compliance; Time Factors; Ultrasonography; Vitamin E | 2003 |
Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
Topics: Adolescent; Adult; Alanine Transaminase; Antioxidants; Biological Availability; Child; Child, Preschool; Cholesterol; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids; Genetic Diseases, X-Linked; Humans; Lipoproteins; Male; Platelet Aggregation; Retinitis Pigmentosa; Safety; Triglycerides; Vitamin A; Vitamin E | 2003 |
Vitamin E supplementation and cataract: randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Capsules; Cataract; Diagnostic Techniques, Ophthalmological; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Lens, Crystalline; Male; Middle Aged; Prospective Studies; Quality Control; Victoria; Vitamin E | 2004 |
The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
Topics: Aged; Antioxidants; Ascorbic Acid; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Double-Blind Method; Female; Haptoglobins; Humans; Lipids; Male; Middle Aged; Phenotype; Postmenopause; Prospective Studies; Vitamin E | 2004 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Double-Blind Method; Humans; Indans; Nootropic Agents; Piperidines; Proportional Hazards Models; Treatment Failure; Vitamin E | 2005 |
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Topics: Adult; Amoxicillin; Ascorbic Acid; China; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Garlic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Phytotherapy; Precancerous Conditions; Prevalence; Selenium; Severity of Illness Index; Stomach Neoplasms; Vitamin E | 2006 |
The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers.
Topics: Antioxidants; Atherosclerosis; Disease Progression; Double-Blind Method; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Regression Analysis; Smoking; Tunica Intima; Ultrasonography; Vitamin E | 2006 |
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Atrophy; Cognition Disorders; Dementia; Disease Progression; Donepezil; Double-Blind Method; Female; Humans; Indans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Nootropic Agents; Piperidines; Predictive Value of Tests; Reproducibility of Results; Temporal Lobe; Vitamin E | 2007 |
Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cell Transformation, Neoplastic; Disease Progression; Double-Blind Method; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Patient Selection; Precancerous Conditions; Risk Assessment; Sample Size; Smoking; Stomach Neoplasms; Treatment Failure; Venezuela; Vitamin E; Vitamins | 2007 |
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Apolipoprotein E4; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Disease Progression; Donepezil; Female; Genotype; Humans; Indans; Linear Models; Male; Neuropsychological Tests; Piperidines; Placebo Effect; Predictive Value of Tests; Prognosis; Sex Distribution; Vitamin E | 2007 |
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group.
Topics: Aged; Antioxidants; Antiparkinson Agents; Disabled Persons; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Selegiline; Treatment Outcome; Vitamin E | 1996 |
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.
Topics: Aged; Antioxidants; Antiparkinson Agents; Disabled Persons; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Selegiline; Treatment Outcome; Vitamin E | 1996 |
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Chemoprevention; Chronic Disease; Disease Progression; Female; Gastric Juice; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Middle Aged; Pilot Projects; Precancerous Conditions; Stomach Neoplasms; Venezuela; Vitamin E; Vitamins | 1996 |
Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atheroscerosis.
Topics: Apolipoproteins; Arteriosclerosis; Ascorbic Acid; Centrifugation, Density Gradient; Coronary Artery Bypass; Disease Progression; Follow-Up Studies; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Triglycerides; Vitamin E | 1995 |
Association between low plasma vitamin E concentration and progression of early cortical lens opacities.
Topics: Adult; Anticholesteremic Agents; Arteriosclerosis; Cataract; Chromatography, High Pressure Liquid; Disease Progression; Finland; Humans; Linear Models; Male; Middle Aged; Pravastatin; Risk Factors; Time Factors; Vitamin E | 1996 |
Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Carotid Artery Diseases; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Intracranial Arteriosclerosis; Male; Ramipril; Research Design; Risk Factors; Ultrasonography; Vitamin E | 1996 |
Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering.
Topics: Adult; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotid Arteries; Cholesterol; Disease Progression; Humans; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography; Vitamin E | 1996 |
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cognition; Disease Progression; Double-Blind Method; Drug Combinations; Female; Humans; Institutionalization; Male; Mental Status Schedule; Monoamine Oxidase Inhibitors; Proportional Hazards Models; Selegiline; Treatment Outcome; Vitamin E | 1997 |
[Indicators of oxidative stress and the effect of antioxidant treatment in patients with primary Parkinson disease].
Topics: Antioxidants; Ascorbic Acid; Biomarkers; Catalase; Disease Progression; Humans; Malondialdehyde; Monoamine Oxidase Inhibitors; Oxidative Stress; Parkinson Disease; Phospholipases A; Phospholipases A2; Reactive Oxygen Species; Spectrophotometry; Vitamin E | 1998 |
DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.
Topics: Antioxidants; Antiparkinson Agents; Clinical Trials as Topic; Disease Progression; Humans; Neuroprotective Agents; Parkinson Disease; Selegiline; Vitamin E | 1998 |
The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study.
Topics: Aged; Aged, 80 and over; Cataract; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Macula Lutea; Macular Degeneration; Male; Middle Aged; Observer Variation; Prevalence; Reproducibility of Results; Retinal Drusen; Retinitis Pigmentosa; Retrospective Studies; Victoria; Vitamin E | 1999 |
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial.
Topics: Aged; beta Carotene; Disease Progression; Double-Blind Method; Humans; Intermittent Claudication; Male; Middle Aged; Odds Ratio; Surveys and Questionnaires; Vitamin E | 1999 |
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Ascorbic Acid; Cataract; Disease Progression; Drug Monitoring; Follow-Up Studies; Humans; Longitudinal Studies; Macular Degeneration; Middle Aged; Placebos; Prospective Studies; Research Design; Risk Factors; Safety; Vitamin E; Zinc | 1999 |
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).
Topics: Aged; Anticoagulants; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; beta Carotene; Blood Coagulation; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Humans; Male; Niacin; Vitamin E; von Willebrand Factor; Warfarin | 2000 |
Antioxidant profile and early outcome in stroke patients.
Topics: Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Brain Ischemia; Chromatography, High Pressure Liquid; Disease Progression; Erythrocytes; Female; Glutathione Peroxidase; Humans; Longitudinal Studies; Male; Oxidative Stress; Severity of Illness Index; Spectrophotometry; Stroke; Superoxide Dismutase; Treatment Outcome; Uric Acid; Vitamin A; Vitamin E | 2000 |
Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.
Topics: Aged; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotid Artery Diseases; Disease Progression; Double-Blind Method; Drug Synergism; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Smoking; Vitamin E | 2000 |
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Blood Pressure; Carotid Artery Diseases; Creatinine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Potassium; Prospective Studies; Ramipril; Risk Factors; Treatment Outcome; Ultrasonography; Vitamin E | 2001 |
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Cataract; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Humans; Lens, Crystalline; Male; Middle Aged; Odds Ratio; Photography; Prospective Studies; Risk Factors; Vision Disorders; Visual Acuity; Vitamin E | 2001 |
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Prospective Studies; Risk Factors; Vision Disorders; Visual Acuity; Vitamin E; Zinc | 2001 |
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract.
Topics: Administration, Oral; Aged; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Cataract; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Micronutrients; Prospective Studies; United Kingdom; United States; Vitamin E | 2002 |
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.
Topics: Antioxidants; Ascorbic Acid; Coronary Artery Disease; Coronary Vessels; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Heart Transplantation; Humans; Male; Middle Aged; Prospective Studies; Tunica Intima; Ultrasonography, Interventional; Vasodilation; Vitamin E | 2002 |
Vitamin E supplementation and macular degeneration: randomised controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Disease Progression; Follow-Up Studies; Humans; Incidence; Macular Degeneration; Middle Aged; Prevalence; Prospective Studies; Victoria; Vitamin E | 2002 |
114 other study(ies) available for d-alpha tocopherol and Disease Exacerbation
| Article | Year |
|---|---|
No association between alpha-tocopherol levels with pulmonary function or exacerbations in cystic fibrosis.
Topics: alpha-Tocopherol; Anti-Bacterial Agents; Cystic Fibrosis; Disease Progression; Humans; Lung; Pseudomonas Infections | 2020 |
Plasma alpha-tochopherol determined by HPLC in dogs at different stages of chronic kidney disease: a retrospective study.
Topics: alpha-Tocopherol; Animals; Case-Control Studies; Chromatography, High Pressure Liquid; Disease Progression; Dog Diseases; Dogs; Female; Male; Renal Insufficiency, Chronic; Retrospective Studies | 2017 |
Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis.
Topics: alpha-Tocopherol; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinogenesis; Cell Adhesion; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Estrogens; Extracellular Matrix; Female; gamma-Tocopherol; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neovascularization, Pathologic; Rats; Rats, Inbred ACI; Signal Transduction; Tocopherols | 2017 |
Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development.
Topics: alpha-Tocopherol; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Dietary Supplements; Disease Progression; Epithelial Cells; Female; Humans; Lipoproteins; Receptor, ErbB-2; Trans-Activators; Vitamin E | 2013 |
Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.
Topics: Adolescent; Adolescent Development; alpha-Tocopherol; Child; Child Development; Child Nutritional Physiological Phenomena; Child, Preschool; Cohort Studies; Cystic Fibrosis; Diet; Dietary Supplements; Disease Progression; Female; Humans; Infant; Intestinal Absorption; Longitudinal Studies; Male; Netherlands; Patient Compliance; Practice Guidelines as Topic; Respiratory System; Retrospective Studies; Vitamin E; Vitamin E Deficiency | 2015 |
7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD.
Topics: Acyl-CoA Oxidase; Adolescent; Adrenoleukodystrophy; Adult; alpha-Tocopherol; Animals; Apoptosis; ATP-Binding Cassette Transporters; Brain; Case-Control Studies; Catalase; Cell Survival; Child; Disease Progression; Docosahexaenoic Acids; Glutathione; Humans; Hydrogen Peroxide; Ketocholesterols; Linoleic Acid; Male; Membrane Proteins; Mice; Microglia; Middle Aged; Oxidative Stress; Peroxisomes; Reactive Oxygen Species; Repressor Proteins; Young Adult | 2017 |
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Topics: Adenocarcinoma; alpha-Tocopherol; Anticarcinogenic Agents; beta Carotene; Biomarkers, Tumor; Carotenoids; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genistein; Humans; Lycopene; Male; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Selenomethionine; Vitamins | 2008 |
Vitamin E and cancer.
Topics: alpha-Tocopherol; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Disease Progression; DNA Damage; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Humans; Mutagenesis; Neoplasms; Organ Specificity; Rats; Vitamin E | 2009 |
Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.
Topics: Adult; alpha-Tocopherol; Atherosclerosis; Biomarkers; Carotid Arteries; Carrier Proteins; Cohort Studies; Disease Progression; Foam Cells; HIV Infections; Humans; Macrophages; Micronutrients; Tunica Intima; Tunica Media; Vitamin E; Vitamin E Deficiency | 2010 |
Relations of serum ascorbic acid and α-tocopherol to periodontal disease.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Dental Care; Dental Devices, Home Care; Diabetes Complications; Disease Progression; Educational Status; Follow-Up Studies; Forecasting; Humans; Longitudinal Studies; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Index; Prospective Studies; Risk Factors; Smoking; Social Class; Toothbrushing; Vitamins | 2012 |
Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Topics: Aged; alpha-Tocopherol; Arachidonic Acid; Carcinoma, Hepatocellular; Case-Control Studies; Chromatography, Gas; Chromatography, High Pressure Liquid; Disease Progression; Enzyme-Linked Immunosorbent Assay; Fatty Acids; Female; Hepatitis C; Humans; Leukocytes, Mononuclear; Liver Cirrhosis; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Phospholipids; Platelet Count; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2003 |
Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.
Topics: Aged; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Ascorbic Acid; Biomarkers; Cerebral Ventricles; Disease Progression; F2-Isoprostanes; Female; Humans; Lipid Peroxidation; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Statistics as Topic; tau Proteins | 2004 |
Effects on neural function of repleting vitamin E-deficient rats with alpha-tocopherol.
Topics: alpha-Tocopherol; Animals; Disease Models, Animal; Disease Progression; Electrophysiology; Electroretinography; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Longitudinal Studies; Male; Neural Conduction; Neurons; Rats; Rats, Wistar; Reproducibility of Results; Vitamin E Deficiency | 2006 |
Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells.
Topics: alpha-Tocopherol; Antioxidants; Cell Line, Tumor; Cell Survival; Dinoprostone; Disease Progression; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Lung; Reactive Oxygen Species; Tocopherols; Vitamin E | 2006 |
Advanced but not localized prostate cancer is associated with increased oxidative stress.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Androgen Antagonists; Biopsy; Bone Neoplasms; Cohort Studies; Disease Progression; Humans; Lipid Peroxidation; Lymphatic Metastasis; Male; Malondialdehyde; Middle Aged; Neoplasm Staging; Oxidative Stress; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Reference Values; Risk Factors; Uric Acid | 2007 |
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
Topics: Aged; alpha-Tocopherol; Ascorbic Acid; Biomarkers; Case-Control Studies; Chronic Disease; Cysteine; Dipeptides; Disease Progression; Female; Glutathione; Heart Failure; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Oxidative Stress; Research Design; Sulfhydryl Compounds | 2007 |
Atherosclerosis: cell biology and lipoproteins.
Topics: alpha-Tocopherol; Animals; Arteriosclerosis; Disease Progression; Humans; Lipoproteins; Lipoproteins, LDL; Oxidative Stress; Protein Kinase C | 2001 |
Is the clinical course of non-arteritic ischemic optic neuropathy associated with oxidative damage and the dynamics of the antioxidant response?
Topics: Antioxidants; Disease Progression; Humans; Optic Disk; Optic Neuropathy, Ischemic; Oxidative Stress; Vitamin E | 2023 |
Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Catechin; Disease Models, Animal; Disease Progression; Male; Mental Health; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Risk Factors; Selenium; Vitamin E | 2021 |
Treatment of NASH: What Helps Beyond Weight Loss?
Topics: Alcohol Drinking; Comorbidity; Diagnosis, Differential; Diagnostic Imaging; Disease Progression; Humans; Hypoglycemic Agents; Liver Function Tests; Non-alcoholic Fatty Liver Disease; Patient Care Planning; Pioglitazone; Prognosis; Risk Assessment; Risk Factors; Vitamin E; Weight Loss | 2017 |
Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cricetinae; Diet, High-Fat; Disease Progression; Humans; Liver; Male; Mesocricetus; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Oncogene Protein p55(v-myc); Protein Kinases; S-Adenosylmethionine; Selenium; Vitamin E | 2019 |
Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts.
Topics: Adolescent; Adult; Case-Control Studies; Child; Disease Progression; Family Characteristics; Female; Humans; Incidence; Logistic Models; Male; Peru; Risk Factors; Socioeconomic Factors; Tuberculosis, Pulmonary; Vitamin E; Vitamin E Deficiency; Young Adult | 2018 |
Dietary antioxidant intake decreases carotid intima media thickness in women but not in men: A cross-sectional assessment in the Kardiovize study.
Topics: Adipose Tissue; Adult; Antioxidants; Ascorbic Acid; Atherosclerosis; Body Mass Index; Carotenoids; Carotid Intima-Media Thickness; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Dietary Supplements; Disease Progression; Female; Humans; Male; Middle Aged; Selenium; Sex Factors; Triglycerides; Vitamin A; Vitamin E; Waist-Hip Ratio; Zinc | 2019 |
Kidney disease and organ transplantation in methylmalonic acidaemia.
Topics: Amino Acid Metabolism, Inborn Errors; Carnitine; Child; Child, Preschool; Creatinine; Cystatin C; Disease Progression; Female; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Male; Nephritis, Interstitial; Postoperative Complications; Renal Dialysis; Retrospective Studies; Ubiquinone; Vitamin B 12; Vitamin E | 2019 |
Vitamin E and Alzheimer's disease: the mediating role of cellular aging.
Topics: Alzheimer Disease; Biomarkers; Case-Control Studies; Cellular Senescence; Cohort Studies; Disease Progression; Female; Humans; Male; Oxidative Stress; Telomere Homeostasis; Vitamin E | 2020 |
Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Biomarkers; Chi-Square Distribution; Cholesterol; Cognition; Cognitive Dysfunction; Disease Progression; Female; Finland; Humans; Incidence; Linear Models; Logistic Models; Male; Odds Ratio; Oxidative Stress; Prospective Studies; Risk Factors; Time Factors; Tocopherols; Tocotrienols; Vitamin E | 2013 |
ACEMg supplementation ameliorates progressive Connexin 26 hearing loss in a child.
Topics: Antioxidants; Ascorbic Acid; Audiometry, Pure-Tone; Child; Connexin 26; Connexins; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hearing Loss, Sensorineural; Humans; Magnesium; Male; Severity of Illness Index; Treatment Outcome; Vitamin A; Vitamin E | 2014 |
Antioxidants accelerate lung cancer progression in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; DNA Damage; Fibroblasts; Humans; Lung Neoplasms; Mice; Reactive Oxygen Species; Solubility; Tumor Suppressor Protein p53; Vitamin E | 2014 |
Application of vitamin E to antagonize SWCNTs-induced exacerbation of allergic asthma.
Topics: Animals; Asthma; Cytokines; Disease Models, Animal; Disease Progression; Immunoglobulin E; Immunoglobulin G; Lung; Male; Nanotubes, Carbon; Ovalbumin; Rats; Vitamin E | 2014 |
[Vitamin E delays Alzheimer disease progression only slightly].
Topics: Aged; Alzheimer Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Memantine; Randomized Controlled Trials as Topic; Vitamin E | 2014 |
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Topics: Aconitate Hydratase; Aged; Alzheimer Disease; Biomarkers; Blotting, Western; Cognitive Dysfunction; Disease Progression; Female; Free Radicals; Humans; Lymphocytes; Male; Mental Status Schedule; Mitochondria; Polymerase Chain Reaction; RNA, Messenger; Vitamin E | 2015 |
Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.
Topics: Alleles; Animals; Antioxidants; Apolipoproteins E; Brachiocephalic Trunk; Dietary Supplements; Disease Progression; Genotype; Haptoglobins; Homozygote; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxygen; Plaque, Atherosclerotic; Vitamin E | 2015 |
Oxidative stress, antioxidants and periodontal disease.
Topics: Antioxidants; Carotenoids; Disease Progression; Humans; Lycopene; Oxidative Stress; Periodontal Diseases; Prevalence; Risk Factors; Tea; United States; Vitamin E | 2015 |
Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
Topics: Animal Feed; Animals; Choline Deficiency; Diet; Disease Models, Animal; Disease Progression; Hepatectomy; Lipid Peroxidation; Liver Regeneration; Male; Mice; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Vitamin E | 2015 |
Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
Topics: Aging; Aldehyde Reductase; Animals; Antioxidants; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; L-Iditol 2-Dehydrogenase; Lens, Crystalline; Mice; Mice, Knockout; Mutation; Osmosis; Oxidative Stress; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Sorbitol; Vitamin E | 2008 |
Plasma urate and progression of mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Boston; Cognition Disorders; Confounding Factors, Epidemiologic; Dementia; Disease Progression; Donepezil; Female; Humans; Incidence; Indans; Male; Middle Aged; Nootropic Agents; Piperidines; Prevalence; Survival Analysis; Uric Acid; Vitamin E | 2009 |
Determinants of platelet activation in hypertensives with microalbuminuria.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Disease Progression; Endothelium; Female; Humans; Hypertension; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Oxidative Stress; P-Selectin; Platelet Activation; Prostaglandins A; Thromboxane B2; Vitamin E | 2009 |
Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Apoptosis; Collagen; Disease Models, Animal; Disease Progression; Fibrosis; Glucosephosphate Dehydrogenase; HSP47 Heat-Shock Proteins; Hydrogen Peroxide; Ischemia; Kidney; Lipid Peroxidation; Male; Metalloporphyrins; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxidative Stress; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Reperfusion Injury; S100 Calcium-Binding Protein A4; S100 Proteins; Superoxide Dismutase; Time Factors; Tyrosine; Vitamin E | 2009 |
Vitamin E does not regress hypercholesterolemic atherosclerosis.
Topics: Animals; Antioxidants; Aorta; Aortic Diseases; Atherosclerosis; Disease Models, Animal; Disease Progression; Female; Hypercholesterolemia; Leukocytes; Lipids; Malondialdehyde; Oxidative Stress; Rabbits; Reactive Oxygen Species; Time Factors; Vitamin E | 2009 |
Biochemical evidence of atherosclerosis progression mediated by increased oxidative stress in apolipoprotein E-deficient spontaneously hyperlipidemic mice exposed to chronic cigarette smoke.
Topics: Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Hyperlipidemias; Male; Mice; Nicotiana; Oxidative Stress; Smoke; Tobacco Smoke Pollution; Vitamin E | 2009 |
Correlation between neurological dysfunction with vitamin E deficiency and gastrectomy.
Topics: Administration, Oral; Aged; Antioxidants; Ataxia; Carcinoma; Disease Progression; Dizziness; Dose-Response Relationship, Drug; Female; Gastrectomy; Humans; Male; Middle Aged; Nervous System; Nervous System Diseases; Peripheral Nervous System Diseases; Recovery of Function; Stomach Neoplasms; Time; Time Factors; Tocopherols; Treatment Outcome; Vitamin E; Vitamin E Deficiency | 2009 |
Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Carotid Arteries; Cross-Sectional Studies; Disease Progression; Female; HIV Infections; Humans; Lipoproteins; Longitudinal Studies; Male; Micronutrients; Middle Aged; Selenium; Tunica Intima; Tunica Media; Viral Load; Vitamin A; Vitamin E; Zinc | 2010 |
Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Blood Platelets; Carotenoids; Dietary Supplements; Disease Progression; Immunohistochemistry; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neovascularization, Pathologic; Platelet Adhesiveness; Platelet Factor 4; Prostatic Neoplasms; Proteomics; Selenium; Time Factors; Tumor Burden; Up-Regulation; Vitamin E | 2010 |
Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Ascorbic Acid; Ascorbic Acid Deficiency; Atherosclerosis; Brain; Dietary Supplements; Disease Models, Animal; Disease Progression; Female; L-Gulonolactone Oxidase; Lipid Peroxidation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Organic Anion Transporters, Sodium-Dependent; Oxidative Stress; Severity of Illness Index; Sex Factors; Sodium-Coupled Vitamin C Transporters; Symporters; Time Factors; Vitamin E; Vitamin E Deficiency; Vitamins | 2010 |
The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits.
Topics: Actin Cytoskeleton; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Heart Failure; Imidazoles; Male; Myocardial Contraction; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrimidines; Rabbits; Reactive Oxygen Species; Ventricular Function, Left; Vitamin E | 2010 |
Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Female; Follow-Up Studies; Genotype; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Vitamin E | 2010 |
Report of the task force on designing clinical trials in early (predementia) AD.
Topics: Advisory Committees; Alzheimer Disease; Amyloidogenic Proteins; Biomarkers; Clinical Trials as Topic; Cognition; Consensus; Disease Progression; Donepezil; Drug Industry; Early Diagnosis; Europe; Humans; Indans; International Cooperation; Nootropic Agents; Outcome Assessment, Health Care; Patient Selection; Piperidines; Positron-Emission Tomography; Research Design; Treatment Outcome; United States; United States Food and Drug Administration; Vitamin E | 2011 |
Inhibition of premature death by isothiocyanates through immune restoration in LP-BM5 leukemia retrovirus-infected C57BL/6 mice.
Topics: Animals; Cytokines; Disease Progression; Female; Isothiocyanates; Lipid Peroxidation; Longevity; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Oxidative Stress; Sulfoxides; Th1 Cells; Th2 Cells; Thiocyanates; Vitamin E | 2011 |
Dietary antioxidants and periodontal disease in community-based older Japanese: a 2-year follow-up study.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Multivariate Analysis; Periodontal Diseases; Periodontium; Poisson Distribution; Retrospective Studies; Surveys and Questionnaires; Tooth; Vitamin E | 2013 |
Plasma non-enzymatic antioxidants-vitamin C, E, beta-carotenes, reduced glutathione levels and total antioxidant activity in oral sub mucous fibrosis.
Topics: Adult; Antioxidants; Areca; beta Carotene; Biomarkers; Case-Control Studies; Disease Progression; Down-Regulation; Female; Glutathione; Humans; India; Male; Mastication; Mouth Neoplasms; Nuts; Oral Submucous Fibrosis; Oxidative Stress; Precancerous Conditions; Vitamin A; Vitamin E; Young Adult | 2012 |
The importance of preclinical trial timing - a potential reason for the disconnect between mouse studies and human clinical trials in ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antioxidants; Ceftriaxone; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mice; Mice, Transgenic; Minocycline; Research Design; Superoxide Dismutase; Treatment Outcome; Vitamin E | 2012 |
Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond.
Topics: Aged; Antioxidants; Ascorbic Acid; Brachial Artery; Case-Control Studies; Cross-Sectional Studies; Disease Progression; Female; Heart Failure; Heart Transplantation; Humans; Hyperemia; Male; Middle Aged; Oxidative Stress; Stroke Volume; Thioctic Acid; Vasodilation; Vitamin E | 2012 |
What are the antioxidant status predictors' factors among male chronic obstructive pulmonary disease (COPD) patients?
Topics: Adult; Antioxidants; Ascorbic Acid; Cross-Sectional Studies; Disease Progression; Forced Expiratory Volume; Humans; Malaysia; Male; Nutritional Status; Outpatients; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Vitamin A; Vitamin E; Vitamins | 2012 |
Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.
Topics: Animals; Apoptosis; bcl-X Protein; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Caspase 3; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Genotype; Homeodomain Proteins; Mice; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Survival; Trans-Activators; Transcription Factor RelA; Vitamin E | 2013 |
Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
Topics: Aged; Alzheimer Disease; Biomarkers; Chromans; Chromatography, High Pressure Liquid; Diagnosis, Differential; Disease Progression; Female; gamma-Tocopherol; Humans; Magnetic Resonance Imaging; Male; Prognosis; Reproducibility of Results; Severity of Illness Index; Tocotrienols; Vitamin E | 2013 |
Effect of vitamins E and C on transplant-associated atherosclerosis.
Topics: Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Disease Progression; Humans; Organ Transplantation; Vitamin E | 2002 |
Effect of vitamins E and C on transplant-associated atherosclerosis.
Topics: Antioxidants; Ascorbic Acid; Coronary Artery Disease; Disease Progression; Humans; Organ Transplantation; Vitamin E | 2002 |
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions.
Topics: Animals; Aorta; Arteriosclerosis; Biomarkers; Cholesterol; Dietary Fats; Dietary Supplements; Dinoprost; Disease Progression; Immunohistochemistry; Lipid Peroxidation; Mice; Mice, Knockout; Nitric Oxide; Receptors, LDL; Treatment Outcome; Triglycerides; Vitamin E | 2003 |
Vitamin E treatment affects the progression of mild cognitive impairment to dementia.
Topics: Antioxidants; Cognition Disorders; Dementia; Disease Progression; Humans; Memory Disorders; Vitamin E | 2003 |
Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism.
Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Biomarkers; Blood Proteins; Cholesterol, HDL; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypercholesterolemia; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Models, Cardiovascular; Myocardial Contraction; Myocytes, Smooth Muscle; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rabbits; RNA, Messenger; Serotonin Antagonists; Succinates; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |
The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
Topics: Aged; Animals; Antioxidants; Coenzymes; Disease Progression; Dose-Response Relationship, Drug; Drug Interactions; Humans; Middle Aged; Parkinson Disease; Rats; Treatment Outcome; Ubiquinone; Vitamin E | 2003 |
[Effect of vitamin E therapy on progression of diabetic nephropathy].
Topics: Albuminuria; Antioxidants; Diabetic Nephropathies; Disease Progression; Humans; Middle Aged; Oxidative Stress; Vitamin E | 2003 |
Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Chronic Disease; Disease Progression; Glomerulonephritis; Hemodynamics; Humans; Oxidative Stress; Renal Insufficiency; Vasodilator Agents; Vitamin E | 2003 |
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Clinical Trials as Topic; Dietary Supplements; Disease Progression; Humans; Macular Degeneration; Middle Aged; Public Health; Risk Reduction Behavior; United States; Vision Disorders; Vitamin E; Zinc | 2003 |
AREDS--two years later.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Macular Degeneration; Public Health; Risk Reduction Behavior; United States; Vision Disorders; Vitamin E; Zinc | 2003 |
Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Antioxidants; Brain; Dietary Supplements; Disease Models, Animal; Disease Progression; Lipid Peroxidation; Mice; Mice, Transgenic; Oxidative Stress; Plaque, Amyloid; Time Factors; Vitamin E | 2004 |
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
Topics: Anemia; Anemia, Sickle Cell; Arteriovenous Shunt, Surgical; Blood Transfusion; Chronic Disease; Darbepoetin alfa; Diabetic Nephropathies; Disease Progression; Erythropoiesis; Erythropoietin; Europe; Evidence-Based Medicine; Ferritins; Hematocrit; Hematologic Tests; Hemoglobinometry; Hemoglobins; Hemorheology; Humans; Iron; Kidney Failure, Chronic; Nutritional Physiological Phenomena; Oxidative Stress; Quality of Life; Recombinant Proteins; Red-Cell Aplasia, Pure; Renal Dialysis; Review Literature as Topic; Transferrin; Treatment Failure; Vitamin E | 2004 |
Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; DNA Primers; Female; Fibronectins; Kidney Function Tests; Lipids; Polymerase Chain Reaction; Pyridoxamine; Rats; Rats, Sprague-Dawley; Thioctic Acid; Vitamin E | 2004 |
[Effects of treatments on serum vitamin E levels in lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Disease Progression; Humans; Lung Neoplasms; Vitamin E | 2004 |
Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Butylated Hydroxytoluene; Carbolines; Cataract; Crystallins; Diabetes Mellitus, Experimental; Dietary Supplements; Disease Progression; Drug Combinations; Lens, Crystalline; Male; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Wistar; Vitamin E | 2005 |
Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Diet, Atherogenic; Disease Progression; Drugs, Chinese Herbal; Hypercholesterolemia; Male; Rabbits; Vitamin E | 2005 |
Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Nootropic Agents; Piperidines; Treatment Failure; Vitamin E | 2005 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Data Interpretation, Statistical; Disease Progression; Donepezil; Heterozygote; Humans; Indans; Piperidines; Vitamin E | 2005 |
Take supplements with a grain of salt.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Macular Degeneration; Vitamin E; Zinc | 2005 |
Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Disease Progression; Endothelium, Vascular; Female; Heart Transplantation; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Middle Aged; Oxidative Stress; Ultrasonography, Interventional; Vitamin E | 2006 |
Effect of oral vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Cytoplasmic Granules; Disease Progression; Dose-Response Relationship, Drug; Gastric Mucosa; Glutathione Peroxidase; Hexosamines; Histamine; Lipid Peroxidation; Male; Mast Cells; Neutrophil Infiltration; p-Methoxy-N-methylphenethylamine; Peroxidase; Rats; Rats, Wistar; Regional Blood Flow; Serotonin; Stomach Ulcer; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E; Xanthine Oxidase | 2006 |
[Influence of antioxidants on the development of benign prostatic hyperplasia].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Ascorbic Acid; beta Carotene; Biomarkers; Chromatography, High Pressure Liquid; Disease Progression; Humans; Male; Middle Aged; Oxidative Stress; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Retrospective Studies; Ultrasonography; Vitamin A; Vitamin E | 2006 |
Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat.
Topics: Animals; Antioxidants; Creatinine; Disease Progression; Glomerulosclerosis, Focal Segmental; Kidney; Male; NADP; Nephrectomy; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxides; Vitamin E | 2007 |
The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.
Topics: Adult; Aged; Antioxidants; Cytokines; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silybum marianum; Silymarin; Time Factors; Transaminases; Treatment Outcome; Ultrasonography; Vitamin E | 2007 |
[IgA nephropathy: modulation of progression by vitamin E, tonsillectomy, steroid and cytotoxic].
Topics: Disease Progression; Glomerulonephritis, IGA; Humans; Steroids; Tonsillectomy; Vitamin E | 2007 |
Biochemical effects of pretreatment with vitamins E and C in rats submitted to intrastriatal hypoxanthine administration.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Corpus Striatum; Disease Progression; Free Radicals; Hypoxanthine; Lesch-Nyhan Syndrome; Oxidative Stress; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Superoxide Dismutase-1; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamin E | 2008 |
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Aneuploidy; Ascorbic Acid; Barrett Esophagus; Cell Transformation, Neoplastic; Chemoprevention; Cohort Studies; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Endoscopy; Esophageal Neoplasms; Female; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Vitamin E; Vitamins | 2008 |
Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort.
Topics: Aged; Aged, 80 and over; Antioxidants; Cholesterol; Cognition Disorders; Cohort Studies; Confidence Intervals; Dementia; Disease Progression; Female; Humans; Incidence; Italy; Male; Multivariate Analysis; Odds Ratio; Prevalence; Risk Factors; Tocopherols; Vitamin E | 2008 |
Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
Topics: Aged; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clinical Protocols; Contraindications; Diabetes Complications; Disease Progression; Epidemiologic Methods; Family Practice; Feasibility Studies; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Patient Selection; Primary Prevention; Risk Factors; Thrombosis; Vitamin E | 1995 |
Alpha tocopherol improves focal glomerulosclerosis in rats with adriamycin-induced progressive renal failure.
Topics: Animals; Disease Models, Animal; Disease Progression; Doxorubicin; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Kidney; Male; Nephrotic Syndrome; Rats; Rats, Inbred Lew; Renal Insufficiency; Vitamin E | 1994 |
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
Topics: Aged; Arteriosclerosis; Autoantibodies; Carotid Artery Diseases; Cholesterol, LDL; Cross Reactions; Disease Progression; Female; Humans; In Vitro Techniques; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Serum Albumin; Vitamin E | 1994 |
Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Cohort Studies; Disease Progression; Feeding Behavior; Female; Humans; Incidence; Knee Joint; Male; Micronutrients; Osteoarthritis; Retrospective Studies; Vitamin E | 1996 |
Tumor progression and oxidant-antioxidant status.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Breast Neoplasms; Cholesterol; Colorectal Neoplasms; Cross-Sectional Studies; Disease Progression; Female; Humans; Male; Malondialdehyde; Middle Aged; Neoplasms; Oxidants; Vitamin E | 1996 |
Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy.
Topics: Aging; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Weakness; Muscular Dystrophy, Animal; Phenotype; Seeds; Software; Statistics as Topic; Triticum; Vitamin E | 1996 |
Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain; Cyclohexanecarboxylic Acids; Diet; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Mice; Mice, Transgenic; Oxidative Stress; Riluzole; Spinal Cord; Superoxide Dismutase; Survival Analysis; Thiazoles; Vitamin E | 1996 |
Correlation of repressed transcription of alpha-tocopherol transfer protein with serum alpha-tocopherol during hepatocarcinogenesis.
Topics: Aged; Animals; Carcinogens; Carcinoma, Hepatocellular; Carrier Proteins; Cholesterol; Diethylnitrosamine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Hyperplasia; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Middle Aged; Neoplasm Proteins; Rats; Rats, Wistar; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Vitamin A; Vitamin E; Vitamin E Deficiency | 1997 |
Study suggests antioxidants slow decline in Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Selegiline; Vitamin E | 1997 |
Selegiline and vitamin E in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Disease Progression; Drug Combinations; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Reproducibility of Results; Selegiline; Treatment Outcome; Vitamin E | 1997 |
Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Topics: Aging; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Chromatography, High Pressure Liquid; Disease Progression; Free Radicals; Immunohistochemistry; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Transgenic; Motor Neurons; Paralysis; Spinal Cord; Vitamin E | 1998 |
The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Body Weight; Disease Progression; Free Radical Scavengers; Half-Life; Mice; Mice, Transgenic; Point Mutation; Vitamin E | 1998 |
Ask the doctor. In your article on Alzheimer's disease (March, 1999), you mention "high doses of vitamin E" as helpful in slowing the progression of the condition. Specifically, what dose is recommended?
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Vitamin E | 1999 |
Preventive effect of topical vitamin E-containing liposome instillation on the progression of galactose cataract. Comparison between 5-week- and 12-week-old rats fed a 25% galactose diet.
Topics: Animals; Body Water; Cataract; Disease Progression; Drug Carriers; Galactitol; Galactose; Glutathione; Lens, Crystalline; Lipid Peroxides; Liposomes; Male; Rats; Rats, Wistar; Vitamin E | 1999 |
Effects of dietary iron overload on progression in chemical hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Apoptosis; Carcinogens; Carcinoma, Hepatocellular; Cell Division; Chromatography, High Pressure Liquid; Diethylnitrosamine; Disease Progression; Glutathione Transferase; Hemochromatosis; Iron; Iron, Dietary; Liver; Liver Neoplasms, Experimental; Male; Oxidative Stress; Rats; Rats, Wistar; Ubiquinone; Vitamin E | 1999 |
Relationship of serum cholesterols and vitamin E to depressive status in the elderly.
Topics: Age Factors; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cross-Sectional Studies; Depression; Disease Progression; Educational Status; Female; Geriatric Assessment; Humans; Longitudinal Studies; Male; Multivariate Analysis; Rural Health; Sex Factors; Vitamin E | 1999 |
Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia.
Topics: Adolescent; Adult; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Carotid Arteries; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; DNA; Female; Heptanoic Acids; Homozygote; Humans; Hyperlipoproteinemia Type II; Male; Mutation; Pyrroles; Receptors, LDL; Simvastatin; Treatment Outcome; Triglycerides; Tunica Intima; Vitamin E | 1999 |
Diet restriction increases ubiquinone contents and inhibits progression of hepatocellular carcinoma in the rat.
Topics: 2-Acetylaminofluorene; Animals; Antioxidants; Apoptosis; Carcinogens; Cell Division; Diethylnitrosamine; Disease Progression; Energy Intake; Glutathione Transferase; Liver; Liver Neoplasms, Experimental; Male; Oxidation-Reduction; Rats; Rats, Wistar; Ubiquinone; Vitamin E | 2000 |
Decreased antioxidant defence in individuals infected by the human immunodeficiency virus.
Topics: Adult; Antioxidants; Ascorbic Acid; beta Carotene; CD4-CD8 Ratio; Disease Progression; Female; Glutathione Peroxidase; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Reactive Oxygen Species; Superoxide Dismutase; Vitamin E | 2000 |
Ataxia caused by mutations in the alpha-tocopherol transfer protein gene.
Topics: Ataxia; Carrier Proteins; Deafness; Disease Progression; Electrocardiography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mutation; Retinitis Pigmentosa; Urination Disorders; Ventricular Premature Complexes; Vitamin E; Vitamin E Deficiency | 2000 |
Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Body Water; Cataract; Cholesterol; Diet; Disease Progression; Drug Carriers; Galactitol; Galactose; Galactosemias; Glutathione; Lens, Crystalline; Lipid Peroxides; Liposomes; Male; Phosphatidylcholines; Rats; Rats, Wistar; Vitamin E | 2000 |
Antioxidative treatment retards progression of idiopathic membranous nephropathy.
Topics: Acetylcysteine; Adult; Antioxidants; Ascorbic Acid; beta Carotene; Complement Membrane Attack Complex; Disease Progression; Glomerulonephritis, Membranous; Humans; Kidney; Male; Selenium; Thiobarbituric Acid Reactive Substances; Time Factors; Vitamin E | 2000 |
Progression after release of obstructive nephropathy.
Topics: Animals; Apoptosis; Blotting, Northern; Disease Progression; HSP70 Heat-Shock Proteins; In Situ Nick-End Labeling; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Ureteral Obstruction; Vitamin E | 2001 |
Further evidence that oxidative stress may be a risk factor responsible for the development of atherosclerosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Ascorbic Acid; Biomarkers; Chromatography, High Pressure Liquid; Deoxyguanosine; Disease Progression; DNA; Female; Ferritins; Humans; Iron; Lymphocytes; Male; Middle Aged; Oxidative Stress; Risk Factors; Transferrin; Vitamin A; Vitamin E | 2001 |
[Ramipril can do more. Halting progression of atherosclerosis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Carotid Stenosis; Disease Progression; Humans; Ramipril; Randomized Controlled Trials as Topic; Vitamin E | 2001 |
Antioxidants, zinc, and age-related macular degeneration: results and recommendations.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Macular Degeneration; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E; Zinc | 2001 |
Lipid peroxidation and platelet activation in murine atherosclerosis.
Topics: Animals; Antioxidants; Aorta; Arteriosclerosis; Cyclooxygenase Inhibitors; Diet, Atherogenic; Dietary Supplements; Dinoprost; Disease Models, Animal; Disease Progression; Female; Immunohistochemistry; Indomethacin; Lipid Peroxidation; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activation; Receptors, LDL; Thromboxane A2; Thromboxane B2; Vitamin E | 2001 |
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Aorta; Aortic Diseases; Arteriosclerosis; Cholestyramine Resin; Disease Progression; Female; Hypercholesterolemia; Linoleic Acid; Lipid Peroxidation; Malondialdehyde; Pregnancy; Rabbits; Vitamin E | 2001 |
Oxidant stress as a marker for cardiovascular events: Ox marks the spot.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Endothelium, Vascular; Forearm; Humans; Nitric Oxide; Oxidative Stress; Predictive Value of Tests; Regional Blood Flow; Treatment Outcome; Vasodilation; Vitamin E | 2001 |
Effect of ramipril and vitamin E on atherosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Carotid Artery Diseases; Disease Progression; Humans; Lipoproteins, LDL; Ramipril; Ultrasonography; Vitamin E | 2002 |
Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome.
Topics: Aged; Ascorbic Acid; beta Carotene; Brain Ischemia; Carotenoids; Chromatography, High Pressure Liquid; Disease Progression; Female; Humans; Lipid Peroxidation; Lutein; Lycopene; Male; Malondialdehyde; Oxidative Stress; Stroke; Vitamin A; Vitamin E; Xanthophylls; Zeaxanthins | 2002 |